<DOC>
	<DOCNO>NCT00586157</DOCNO>
	<brief_summary>The purpose study investigate effectiveness medication skin patch call Methylphenidate Transdermal System ( MTS ) . We compare MTS medicate patch placebo patch . We want find well treat ADHD early morning hour child leave school summertime routine .</brief_summary>
	<brief_title>Study Medication Patch Treat Children Ages 6-12 With ADHD</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Male female outpatient 6 12 year age . Diagnosis Attention Deficit Hyperactivity Disorder ( ADHD ) , DSMIV , manifest clinical evaluation confirm structured interview . Participation structure morning routine ( e.g . school , camp , organize activity ) . Mental retardation ( IQ &lt; 75 ) . Subjects medical condition , treatment either jeopardize subject safety affect scientific merit study . Subjects moderate severe dermatological atopy . Subjects know structural cardiac abnormality . Organic brain disorder . Seizure Disorder . Subjects Tourette 's syndrome , history psychosis bipolar disorder . Subjects current comorbid psychopathology investigator 's opinion warrant immediate treatment interfere safe execution protocol ( i.e . Anxiety Major Depressive Disorder rat moderate CGI ) . Subjects history intolerable adverse effect nonresponse methylphenidate . Pregnant nursing female .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>Daytrana</keyword>
	<keyword>MTS Patch</keyword>
	<keyword>Methylphenidate Transdermal System</keyword>
</DOC>